Learn more about our Q3 2025 results

Oriola operates in the Finnish and Swedish health and wellbeing markets

Oriola serves the health and wellbeing market with modern and customer-focused products and services, and connects all actors within the field, from pharmaceutical companies to pharmacies and consumers.

Interim Report Q3 2025

Sales margin growth and improved adjusted EBITDA

Download report Download presentation Watch webcast recording

Oriola's science-based climate targets

Oriola’s ambitious science-based climate targets approved by the SBTi. This approval makes Oriola one of the companies globally recognised by the SBTi as having an approved science-based net-zero target under the SBTi Net-Zero Standard.

Shortcut to investor tools

Share information Share monitor Shareholders

Latest stock exchange releases

30.10.2025 | Stock exchange releases

Oriola Corporation’s Interim Report January-September 2025

02.10.2025 | Stock exchange releases

Oriola appoints Maria Lundell as Chief People Officer

24.09.2025 | Stock exchange releases

Publication schedule for Oriola Corporation's financial reporting in 2026

Latest investor news

17.11.2025 | Press releases

Oriola initiates change negotiations in connection with plans for a new distribution centre in Finland

16.10.2025 | Press releases

Oriola Corporation to publish its Interim Report for January-September 2025 on 30 October 2025

04.07.2025 | Press releases

Oriola Corporation to publish its Half-Year Report for January-June 2025 on 18 July 2025

See all releases from our newsroom Subscribe to releases

Looking for financial reports or other financial information?

Reports and presentations Financial information Investor calendar Investor contacts

Investment for health and wellbeing